新奥尔良Humanitas Global Health启用：获路易斯安那州立大学DeepDrug技术授权
路易斯安那州奥尔良县新奥尔良市消息：新成立的健康科技企业 Humanitas Global Health 10月27日在新奥尔良举行的 AAPS PharmSci 360 大会（10月25日至28日，Morial 会议中心）上宣布启用，并宣布与路易斯安那州立大学（LSU）签署 DeepDrug 技术商业化授权协议。DeepDrug 是 LSU 团队开发的超级智能（SI）药物研发技术。
该公司创办人兼首席执行官为 Chris Galliano。10月27日，该公司在大会主持一场专题讨论；当天下午，LSU 与 DeepDrug 团队在路易斯安那生物技术创新奖仪式上获得表彰，该公司出席了仪式。
来源：GSM·美国
Humanitas Global Health Launches in New Orleans: Signs DeepDrug Technology License With Louisiana State University
NEW ORLEANS, Orleans Parish, Louisiana — Newly launched health technology company Humanitas Global Health announced its launch on October 27 at the AAPS PharmSci 360 conference in New Orleans (October 25-28, Morial Convention Center), together with a commercialization license for the DeepDrug technology from Louisiana State University (LSU). DeepDrug is a superintelligence (SI) drug-discovery technology developed by an LSU team.
The company's founder and CEO is Chris Galliano. On October 27 the company hosted a panel session at the conference; that afternoon, the LSU and DeepDrug team was honored at the Louisiana Biotech Innovation Award ceremony, which the company attended.
Source: GSM · USA
来源：GSM·美国（原文链接）
图片来源：图：新奥尔良 Ernest N. Morial 会议中心（Barry Bahler 摄，公共领域，美国联邦紧急事务管理局，Wikimedia Commons）。The Ernest N. Morial Convention Center in New Orleans (by Barry Bahler, public domain, FEMA, via Wikimedia Commons).
